BioCorRx Inc
OTC:BICX
BioCorRx Inc
Cash from Operating Activities
BioCorRx Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioCorRx Inc
OTC:BICX
|
Cash from Operating Activities
-$1.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-16%
|
|
Universal Health Services Inc
NYSE:UHS
|
Cash from Operating Activities
$1.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Encompass Health Corp
NYSE:EHC
|
Cash from Operating Activities
$861.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Tenet Healthcare Corp
NYSE:THC
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
15%
|
|
HCA Healthcare Inc
NYSE:HCA
|
Cash from Operating Activities
$10.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Cash from Operating Activities
$363.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
26%
|
See Also
What is BioCorRx Inc's Cash from Operating Activities?
Cash from Operating Activities
-1.8m
USD
Based on the financial report for Jun 30, 2023, BioCorRx Inc's Cash from Operating Activities amounts to -1.8m USD.
What is BioCorRx Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-16%
Over the last year, the Cash from Operating Activities growth was 28%. The average annual Cash from Operating Activities growth rates for BioCorRx Inc have been 15% over the past three years , and -16% over the past ten years .